Stanford University
Showing 2,501-2,600 of 13,135 Results
-
Aaron J. Dawes, MD, PhD, FACS, FASCRS
Assistant Professor of Surgery (General Surgery)
BioDr. Dawes is a board-certified, fellowship-trained colon and rectal surgeon. He is also an Assistant Professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Dawes treats a wide variety of conditions involving the colon, rectum, and anus, always leveraging the latest evidence and technologies. He is fully trained in minimally invasive surgical techniques--including laparoscopic, robotic, and trans-anal minimally invasive surgery--and strives to employ them, whenever possible, in an effort to reduce pain and shorten recovery.
In addition to his clinical work, Dr. Dawes is a health services researcher, receiving his Ph.D. in Health Policy and Management from the UCLA Fielding School of Public Health. His research focuses on policy development, measurement, and evaluation for patients with colorectal conditions. He is particularly interested in using data to drive policy interventions aimed at reducing disparities in quality, access, and value.
Prior to joining Stanford, Dr. Dawes completed a residency in General Surgery at the University of California, Los Angeles followed by a fellowship in Colon and Rectal Surgery at the University of Minnesota. He has authored articles in the Journal of the American Medical Association (JAMA), Cancer, Diseases of the Colon and Rectum, Health Services Research, and JAMA Surgery. His work has also been featured in the Los Angeles Times, the Daily Press, and HealthDay News.
A native of the San Francisco Bay Area, Dr. Dawes received his A.B. in Public and International Affairs from Princeton University and his M.D. from Vanderbilt University. -
Brian Dawes
Fellow in Medicine - Med/Infectious Diseases
Current Research and Scholarly InterestsMy current research is focused on better understanding the causes of acute febrile illness in Grenada in collaboration with the Windward Research and Education Foundation (WINDREF). We are conducting an acute febrile illness cohort and performing diagnostics for common arboviral infections including dengue, Zika, and chikungunya viruses. We will use this data to develop better estimates for the incidence of arboviral infections on the island and identify epidemiologic risk factors which could be the target of preventative interventions. This study is also assessing a novel diagnostic system for antigen detections in collaboration with Dr. Ali Yanik at UCSC. We will be testing these samples for hantavirus infections or antibodies to determine if hantaviral infections are clinically important causes of disease in Grenada. In addition, we are performing a pilot ecologic survey of rodents and bats and will attempt to identify circulating hantaviruses in these species.
-
Braden Michael Dawson
Affiliate, Radiology
BioBraden Dawson is an undergraduate student at the University of Southern California studying Legal Studies and Natural Science on pre-medical and pre-law tracks. His work focuses on health policy, healthcare systems, and translational medicine, with interests in healthcare access, implementation, and regulatory design. At Stanford School of Medicine, he is a Canary CREST Research Intern, conducting translational cancer early-detection research under Parag Mallick, PhD.
-
Heather Sydney Day, MS
Biostatistician 2, Stanford-Surgery Policy Improvement Research and Education Center
Current Role at StanfordBiostatistician 2, Stanford-Surgery Policy Improvement Research and Education Center
-
John W. Day, MD, PhD
Professor of Neurology and Neurological Sciences (Adult Neurology), of Pediatrics (Genetics) and, by courtesy, of Pathology
Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.
-
John Robert Dayton
Clinical Assistant Professor, Emergency Medicine
BioBefore becoming an assistant professor, Dr. Dayton was the inaugural Medical Design and Innovation Fellow with Stanford's Department of Emergency Medicine. He also completed a Biodesign Faculty Fellowship with the Byers Center for Biodesign. In addition to practicing medicine, he co-founded the Stanford Emergency Medicine Partnership Program (STEPP), directed two Stanford Emergency Medicine Innovation Symposium (StEMIX) pitch events, and led the 2022 ACEP Hackathon.
Outside of Stanford, Dr. Dayton advises health-tech companies on strategy and physician user experience and works in VC. He co-founded Utah's Society of Physician Entrepreneurs and has served in both state and national leadership positions with the American College of Emergency Physicians (ACEP). He also works with Intermountain Health as an emergency physician and physician advisor to Intermountain Ventures and is a life science investor with Frame VC.
John's areas of expertise include digital therapeutics, healthcare innovation, AI operational tools, medical devices, clinical validation, academic-private pilot partnerships, and venture funding. -
Aglaia Kaissa de Boer
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioKaïssa de Boer, MD is a board certified pulmonologist who specializes in the care of patients with interstitial lung disease. She completed her Internal Medicine and Pulmonary training at the University of Ottawa, Ottawa, Canada where her initial interest in caring for patients with fibrotic lung disease first developed. Subsequently she completed a fellowship in Interstitial Lung Disease at the University of California, San Francisco under the direction of Dr. Harold Collard. Dr. de Boer has a special interest in patients with connective tissue disease associated lung disease and those with drug induced pneumonitis. In addition she is actively involved in the ILD training and program development of Stanford's Pulmonary Allergy and Critical Care Fellows.
-
Mary de Boer
Postdoctoral Scholar, Infectious Diseases
BioI am a maternal and child nutrition researcher with expertise in nutritional epidemiology, implementation science, and environmental health. My work focuses on understanding heterogeneity in health outcomes among pregnant women in low- and middle-income countries — specifically, why evidence-based interventions fail to reach or benefit the most vulnerable subgroups. I use mixed methods combining traditional nutritional epidemiology with spatial analysis, multilevel and structural equation modeling, latent class analysis, and qualitative approaches to understand both biological and structural drivers of that heterogeneity. I come to academic research after 14 years as a field-based public health practitioner in Sub-Saharan Africa and Central Asia within the USAID Foreign Service.
-
Walter De Brouwer
Adjunct Professor, Medicine - Primary Care and Population Health
BioWalter A. De Brouwer, Ph.D., is an Adjunct Professor at the Stanford School of Medicine. As a core faculty member at CERC DICE, he is the course director for “Innovation in Healthcare: from idea to incorporation,” which includes a bi-weekly presentation. He also serves on the advisory committee focused on the strategic direction for the program and is part of the leadership team developing the program curriculum and practicum. He is the founder of doc.ai, a Palo-Alto-based Federated Edge Learning company for the payers/pharma industry which merged in January 2020 with Sharecare Inc.
Professional Education
Bachelor’s degree in Philology (University of Ghent, Belgium)
Master’s degree in Formal Linguistics (University of Ghent, Belgium)
Post-graduate: Epistemology (University of Ghent, Belgium)
Ph.D. Computational Semiotics (Catholic University of Tilburg, the Netherlands). -
Korina De Bruyne
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsThe EMPOWER study (PI: Dr Beth Darnall) is looking at how to best support patients with chronic pain on long-term opioid therapy through a slow taper (maximal duration of 1 year). Patients are randomized to taper only versus taper plus community-based pain self-management group sessions versus taper plus psychologist-led cognitive behavioral therapy for pain group sessions. Along the way alternative measures to control pain are also explored. Enrollment is open until 10/2021.
-
Sallie De Golia
BioDr. De Golia specializes in the treatment of mood and anxiety disorders with an expertise in time-limited dynamic psychotherapy. She is Section Chief of the Assessment Clinics and Director of the Evaluation Clinic. Dr. De Golia is Director of Coaching and Senior Faculty Educational Consultant in Stanford's Department of Psychiatry and Behavioral Sciences. She is a Peer Teaching Coach and Fellow in the Stanford Teaching and Mentoring Academy, has taught regularly with the Stanford Center for Faculty Development, and is a Senior Fellow at Stanford's Center for Innovation in Global Health. She currently serves on the Executive Committee of the American Association of Directors of Psychiatry Residency Training.
-
Michelle de Haaff
Casual - Non-Exempt, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordAssistant Director of Digital Health
Co-Instructor Biodesign for Digital Health (Fall) and Biodesign for Societal Health (Winter)
Stanford Byers Center for Biodesign -
Vinicio de Jesus Perez MD
Associate Dean of Stanford MD Admissions and Professor of Medicine (PACCM)
Current Research and Scholarly InterestsMy research focuses on the molecular and cellular mechanisms that drive pulmonary vascular disease, particularly pulmonary arterial hypertension (PAH). I study how endothelial dysfunction, impaired vascular repair, pericyte abnormalities, inflammation, and metabolic dysregulation contribute to pulmonary vascular remodeling and right ventricular failure. Through the integration of human tissue studies, advanced Omics technologies, and translational animal models, my work aims to identify novel th
-
Francisco M. De La Vega
Adjunct Professor, Biomedical Data Science
BioFrancisco De La Vega is a distinguished geneticist and computational biologist, and an experienced technical executive, widely recognized for his expertise in clinical and population genomics, and bioinformatics. Currently serving as the Vice President of Hereditary Disease at Tempus Labs, Francisco is spearheading the development of comprehensive germline genetic tests and conducting innovative research into racial disparities in cancer leveraging Tempus’ multimodal Real-World Data. His work focuses on uncovering the connections between genetic ancestry and cancer genome mutational profiles that may help explain the differences in cancer incidence and outcomes across races and ethnicities. In addition to his role at Tempus Labs, Francisco is an Adjunct Professor in the Department of Biomedical Data Science at Stanford University School of Medicine and is a member of the Board of Directors of the International Society of Computational Biology, serving from 2022 to 2025.
Francisco teaches BIODS-235: "Best practices for developing data science software for clinical and healthcare applications" every Winter quarter. -
Adam de la Zerda
Associate Professor of Structural Biology and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsMolecular imaging technologies for studying cancer biology in vivo
-
Luis de Lecea
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical and Translational Neurosciences Incubator)
Current Research and Scholarly InterestsMy lab uses molecular, optogenetic, anatomical and behavioral methods to identify and manipulate the neuronal circuits underlying brain arousal, with particular attention to sleep and wakefulness transitions. We are also interested in the changes that occur in neuronal circuits in conditions of hyperarousal such as stress and drug addiction.
-
Helbert de Oliveira Manduca Palmiero
Clinical Instructor, Neurosurgery
BioBoard-Certified Neurosurgeon (Brazilian Society of Neurosurgery, IFAANS, FCNS, FACS) with advanced training in Microsurgery and Complex Spine Surgery. Over the past decade, I have developed a comprehensive portfolio that includes general neurosurgical practice in both Brain & Spine and academic contributions to neurosurgical techniques and anatomical research. I believe in continuous improvement, and my work is driven by a commitment to excellence in neurosurgery, innovation in surgical education, and clinical practice focused on patient outcomes.
-
Maharshi Krishna Deb
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsI aim to gain insights of the molecular underpinnings that are critical for the specification of human germ cells as well as the episode of epigenetic reprogramming that they undergo which is critical for their development and thereby essential for perpetual propagation of human species. Under co-mentorship of Prof. Azim Surani and Dr. Shiv Grewal,I aim to learn these lessons from this immortal lineage of human germline to identify interventions against various pediatric as well as degenerative
-
Charles DeBattista
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult)
Current Research and Scholarly InterestsTreatment resistant depression.
Novel biological interventions in the treatment of mental illness.
Anti-glucocorticoid drugs in the treatment of mood disorders.
Augmentation strategies in the treatment of depression. -
Charles DeBoer, MD, PhD
Assistant Professor of Ophthalmology
BioDr. DeBoer is a board-certified, fellowship-trained vitreoretinal surgeon with Stanford Health Care’s Byers Eye Institute and a clinical instructor in the Department of Ophthalmology.
He specializes in retinal and macular diseases, treating a range of conditions such as retinal tears, diabetic retinopathy, retinal vein occlusions, macular pucker, macular hole, macular degeneration, retinal detachment, and other complex retinal conditions. Dr. DeBoer incorporates state-of-the-art treatments in personalized, comprehensive care plans for each of his patients. He is dedicated to training future vitreoretinal surgeons and passionate about helping patients through both direct care and research.
Dr. DeBoer’s scientific background in micro- and nanofabrication, mechanical and electrical engineering, and medicine drives his research interests in implantable devices and surgical instruments. While completing his PhD, Dr. DeBoer co-invented a biomimetic accommodating intraocular lens (IOL) that treats both cataracts and presbyopia.
He continues researching microdevices, focusing on extended drug delivery from the lens capsule and microelectromechanical systems (MEMS)-enabled implantable devices. Dr. DeBoer’s research experience spans topics such as material science, drug delivery, IOL design, microfabrication, 3D printing, and medical device design. He has received grant funding for his work and has 12 patents in the field of ophthalmology.
Dr. DeBoer’s work has been published in peer-reviewed journals, including the American Journal of Ophthalmology. He has authored book chapters and presented to his peers at national and international meetings, including meetings of the American Society of Retina Specialists and the Association for Research in Vision and Ophthalmology.
Dr. DeBoer is a member of the American Academy of Ophthalmology and American Society of Retina Specialists. He is also part of the Society of HEED Fellows and Ronald G. Michels Fellowship Foundation. -
Robert DeBusk
Professor of Medicine, Emeritus
Current Research and Scholarly InterestsExperimental and clinical epidemiology of myocardial, infarction; exercise testing; cardiac risk factor management;, cardiac rehabilitation; systems for patient management; ischemic, heart disease; computer-based expert systems.
-
Johannes Hugo Decker
Clinical Assistant Professor, Radiology
BioHugo Decker is part of the Diagnostic Radiology resident call of 2018-2022.
He received his BS in Biological Sciences at Stanford in 2008.
He completed his MSTP training at Weill Cornell Medical College in 2017.
He completed his Medical internship at Santa Clara Valley Medical Center in 2018. -
Niki DeGeorge
Associate Director of Radiation Physics, Radiation Oncology
Current Role at StanfordNiki is the Associate Director of Radiation Physics in the Department of Radiation Oncology.
-
Karl Deisseroth
D. H. Chen Professor, Professor of Bioengineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsKarl Deisseroth's laboratory created and developed optogenetics, hydrogel-tissue chemistry (beginning with CLARITY), and a broad range of enabling methods. He also has employed his technologies to discover the neural cell types and connections that cause adaptive and maladaptive behaviors.
-
Cornelia L. Dekker, M.D.
Professor (Research) of Pediatrics (Infectious Diseases), Emerita
Current Research and Scholarly InterestsThe Stanford-LPCH Vaccine Program provides an infrastructure for conducting clinical studies of vaccines in children and adults. We conduct immunology studies of seasonal influenza vaccines in twins, in a longitudinal cohort of young and elderly adults and studies of various vaccine candidates for NIH and industry. Additionally, we were a CDC Clinical Immunization Safety Assessment site for 10 years working on safety issues concerning licensed vaccines.
-
Tina M. Del Cont
Product & Program Manager, Stanford Profiles, Technology & Digital Solutions
Current Role at StanfordI am the Product Manager for Stanford Profiles and Project Manager of the Stanford Profiles University-Wide Project. I work directly with the Stanford Profiles development team in Stanford Medicine | Technology & Digital Solutions Application Development. On this project, I also work with a university-wide project team, the Stanford Profiles (formerly CAP) Working Group, made up of members from many of the Stanford schools and organizations. In June of 2014, we started the CAP Drupal Module Working Group. The purpose of this group is to review and improve the integration process with CAP by expanding and enhancing the CAP Drupal Module (CAPx) with an open-source contribution approach (an initiative started and led by SWS in collaboration with the CAP Drupal Module user community).
If you are interested in becoming part of the Stanford Profiles University-Wide Project, which includes the Stanford Profiles Public and Stanford-only View web sites or would like more information on integrating your web site with Stanford Profiles, contact me at tdelcont@stanford.edu. -
Claudia Del Toro Runzer
Postdoctoral Scholar, Medical Genetics
BioClaudia Del Toro Runzer is a postdoctoral scholar at Stanford University specializing in gene therapy and regenerative medicine. Her current research focuses on developing gene editing strategies for inherited disorders, including GNE myopathy and Gaucher disease. She works on advancing precision gene engineering approaches in human hematopoietic stem and progenitor cells and other clinically relevant cell types, with the goal of enabling safe and durable therapeutic correction.
Dr. Del Toro Runzer earned her PhD in Tissue Engineering from the MERLN Institute for Technology-Inspired Regenerative Medicine at Maastricht University. Her doctoral research focused on chemically modified mRNA therapeutics for bone regeneration, where she investigated molecular design, intracellular trafficking, and biomaterial-assisted delivery systems to enhance protein expression and osteogenic outcomes. Her work resulted in multiple first-author publications in leading journals, including Advanced Functional Materials, Bone Research, Materials Today, and Molecular Therapy: Nucleic Acids.
Prior to her PhD, she completed an M.Sc. in Regenerative Biology and Medicine at Technische Universität Dresden and a B.Sc. in Biotechnology Engineering at Instituto Tecnológico de Monterrey. Her international training spans Germany, the Netherlands, Mexico, and the United States, with research experience in organoid systems, tissue regeneration, biomaterials engineering, and microphysiological platforms. -
Erlynn Dela Cruz
Administrative Associate, Pediatrics - Endocrinology
Current Role at StanfordAdministrative Associate
-
Beverly Jazmine Delgado
Research Coordinator, Dermatology
BioI’m a Research Coordinator at Stanford University, with over three years of experience in medical research and technology development. My work at Wipe Out Melanoma - California (WOM-CA) focuses on the importance of healthcare access and levering technology for early detection of melanoma.
I’ve worked in human subject research involving wearable devices and led hands-on training for study procedures, including data collection and handling. I’m passionate about applying real-life solutions to modern social and healthcare challenges. I’m skilled in data & project management and fluently speak Spanish. -
Juan Delgado
Casual - Non-Exempt, Epidemiology and Population Health
Current Role at StanfordResearch Assistant - Urologic Cancer Epidemiology Lab
-
Daniel James Delitto, MD, PhD, FACS
Assistant Professor of Surgery (General Surgery)
BioDr. Delitto is a board certified complex general surgical oncologist with a focus on conditions of the liver, pancreas, and stomach. He is an assistant professor in Stanford Medicine’s Department of Surgery.
His education includes a decade of postgraduate training in complex general surgical oncology, as well as a PhD in immunology with an emphasis on cancer biology. He completed a clinical fellowship at Johns Hopkins University and continued his research at the postdoctoral level in the laboratory of Dr. Elizabeth Jaffee. His research focus is on advancing the field of cancer immunology and harnessing his findings to improve immunotherapies.
He was the principal investigator of two studies examining the immune response to pancreatic cancer, including one funded by the National Cancer Institute.
Dr. Delitto has presented the findings of his research at conferences such as the American Association for Cancer Research, Society for the Immunotherapy of Cancer, American Association of Immunologists, American College of Surgeons, Academic Surgical Congress and Pancreas Club. In addition to cancer immunology, he has also presented work focused on cancer cachexia, surgical outcomes, translational experimental models and a variety of other oncologic topics.
He has published original work in Nature Communications, the Journal of the National Cancer Institute, Cancer Research, Clinical Cancer Research, and other high impact journals. He is also a reviewer for Annals of Surgery, Scientific Reports, Surgery, Tumor Biology, Journal of Surgical Research, PLOS ONE, and the Journal of Translational Medicine.
Dr. Delitto has earned numerous honors related to clinical excellence, teaching and research. He is board certified by the American Board of Surgery and a member of the Society of Surgical Oncology, American Association for Cancer Research and American Association of Immunologists. -
Scott L. Delp, Ph.D.
Director, Wu Tsai Human Performance Alliance at Stanford, James H. Clark Professor in the School of Engineering, Professor of Bioengineering and of Mechanical Engineering
Current Research and Scholarly InterestsExperimental and computational approaches to study human movement. Development of biomechanical models to analyze muscle function, study movement abnormalities, design medical products, and guide surgery. Imaging and health technology development. Discovering the principles of peak performance to advance human health. Human performance research. Wearable technologies, video motion capture, and machine learning to enable large-scale analysis.
-
Wendy DeMartini
Professor of Radiology (Breast Imaging)
BioDr. Wendy DeMartini is a Professor in the Department of Radiology at Stanford University School of Medicine. She currently serves as the Associate Chair for Clinical Faculty Affairs in the Department of Radiology, and is the past Division Chief of Breast Imaging. Her work is focused upon high quality patient care, clinical research and education.
Dr. DeMartini completed her fellowship in Breast Imaging at the University of Washington School of Medicine in Seattle, Washington. She then served as Breast Imaging faculty at the University of Washington where she became Associate Professor and Associate Director of Clinical Services, and at the University of Wisconsin where she became Professor and Chief of Breast Imaging.
Dr. DeMartini has more than 100 research presentations, abstracts/publications, review articles or book chapters. Her research is directed toward the appropriate evidence-based use of imaging tests to optimize the detection and evaluation of breast cancer. She has served as an investigator on several studies of breast MRI funded by the National Cancer Institute and by the American College of Radiology Imaging Network (ACRIN). Particular research topics have included the development of a pilot tool for predicting the probability of malignancy of breast MRI lesions, assessment of the impact of background parenchymal enhancement (BPE) on breast MRI accuracy, and evaluation of utilization patterns of breast MRI and other emerging technologies. She also served as the Editor-in-Chief of the Journal of Breast Imaging from 2023 to 2024.
Dr. DeMartini is a highly sought-after educator. She lectures on a broad spectrum of breast imaging topics nationally and internationally, including in the Americas, Europe, Australasia and Africa. She is the past Co-Director of the American College of Radiology (ACR) Education Center Breast MRI with Biopsy Course. Dr. DeMartini is an active member of many professional organizations and committees, including in the Radiologic Society of North America, the American College of Radiology and the Society of Breast Imaging (SBI). She was elected as an SBI Fellow in 2009 and served as President of the SBI in 2017-2018. -
Utkan Demirci
Professor of Radiology (Diagnostic Sciences Laboratory) and, by courtesy, of Electrical Engineering
BioDr. Utkan Demirci, UofM’99, Stanford’01’05’05, is a Professor of Radiology (with tenure) and of Electrical Engineering (by courtesy) at the Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, where he leads a productive researcher group. Utkan is a tenured professor at Stanford University School of Medicine. Prior to joining Stanford in 2014, he held the position of Associate Professor at the Brigham and Women’s Hospital-Harvard Medical School and also served at the Harvard-MIT Health Sciences and Technology division. Over the past decade, his research group has focused on the early detection of cancer and has made significant contributions to the development of microfluidic platforms for sorting rare cells and exosomes and point-of-care bio-sensing technologies.
Dr. Demirci leads a productive and impactful research group focused on addressing problems from the clinic with innovations including cell sorter for IVF, optical technologies for detecting viruses, portable point of care technologies for diagnostics in global health, smart robots in vivo, extracellular vesicle based early detection approaches for cancer. He is an elected fellow of the American Institute of Medical and Biological Engineering and The Academy for Radiology & Biomedical Imaging Research Distinguished Investigator.
He has published over 250 peer-reviewed articles, 300 abstracts and proceedings, 24 book chapters and editorials, and 7 edited books. He also serves on the editorial board of various journals. He is a serial academic entrepreneur and co-founded multiple successful companies. His patents are translated into broadly used biomedical products. Dr. Demirci's pioneering work in microfluidics and cell sorting has resulted in CE certified and FDA approved devices used in over 500,000 clinical cases serving patients globally. -
Megan DeMott, MD
Affiliate, Physician Assistant Studies
BioMegan DeMott, MD, earned dual Bachelor of Arts degrees in Biochemistry and Philosophy from Claremont McKenna College, graduating summa cum laude. She received her medical degree from Johns Hopkins University School of Medicine and completed residency training in Emergency Medicine at Henry Ford Hospital in Detroit, where she served as Chief Resident. She went on to complete a fellowship in Medical Toxicology at the University of California, San Diego.
For the past 15 years, Dr. DeMott has practiced at an indigent care hospital in Brawley, California, where she is dedicated to serving underserved populations. In addition to her clinical work, she mentors Stanford physician assistant students, fostering the next generation of healthcare providers. Her professional interests include medical toxicology, emergency care, and health equity in vulnerable communities.
